drugset / Trial / NCT00733538
Stage I Multiple Myeloma Treatment
RandomizedFactorialOpen-labelTreatment
Summary
* Assessment of survival without progression of stage I MM in two groups: arm A: simple survey and arm B: administration of Zoledronate. * Describe different progression's type noticed and define the prognosis factors of a fast evolution.
Timeline
- Start
- 2004-12
- Primary completion
- 2009-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zoledronic acid | Other / unclassified | — | — |